Michael Halstead - 04 Jan 2016 Form 4/A - Amendment Insider Report for Intra-Cellular Therapies, Inc. (ITCI)

Role
EVP and General Counsel
Signature
/s/ Lawrence J. Hineline, Attorney-in-fact
Issuer symbol
ITCI
Transactions as of
04 Jan 2016
Net transactions value
$0
Form type
4/A - Amendment
Filing time
07 Jul 2023, 18:07:59 UTC
Date Of Original Report
06 Jan 2016
Next filing
23 Dec 2021
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction ITCI Stock Option (right to buy) Award $0 +40,472 $0.000000 40,472 04 Jan 2016 Common Stock 40,472 $53.63 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The Stock Option vests as to one third of the shares on January 4, 2017, one third of the shares on January 4, 2018 and one third of the shares on January 4, 2019.

Remarks:

This Form 4/A is being filed solely to correct an error in the number of shares underlying the stock option granted on January 4, 2016.